Open Access 28-04-2024 | Buprenorphine | Correction
Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Published in: Drugs & Therapy Perspectives | Issue 4/2024
Login to get access